Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4
2(50.0%)
Phase 2
1(25.0%)
N/A
1(25.0%)
4Total
Phase 4(2)
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05199324Phase 4Recruiting

Early Oral Switch for Uncomplicated Gram-negative Bacteraemia

Role: collaborator

NCT06762730Phase 4Recruiting

Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Individuals

Role: collaborator

NCT06921343Not ApplicableNot Yet Recruiting

Iron Deficiency in Pediatric Celiac Disease: Diet vs. Iron Supplementation Trial

Role: collaborator

NCT01094158Phase 2Completed

Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis

Role: collaborator

All 4 trials loaded